Jeffrey S Ross MDChairman, Department of Pathology and Laboratory Medicine, Albany Medical College; Pathologist-in-Chief, Albany Medical Center Hospital; President, Affiliated Pathology Services, PC, Albany, New York; Medical Director, Foundation Medicine, Inc, Cambridge, Massachusetts
Jeffrey S. Ross, M.D. is a graduate of Oberlin College, Oberlin, Ohio and The State University of New York at Buffalo School of Medicine in Buffalo, New York. He served as an intern resident and fellow in Anatomic and Clinical Pathology at the Massachusetts General Hospital in Boston, Massachusetts. He was certified by the American Board of Pathology in Anatomic and Clinical Pathology in 1974. Following his training, Dr. Ross served as Chief of Pathology at the Moncrief United States Army Hospital in Fort Jackson, South Carolina. From 1977 until 1989 he was a member of the faculty of the University of Massachusetts Medical School reaching the rank of Professor and Assistant Dean while continuing as research Assistant Professor at Harvard Medical School and the Massachusetts General Hospital. In 1989 he became the Cyrus Strong Merrill Professor and Chairman of the Department of Pathology and Laboratory Medicine at the Albany Medical College and Pathologist-in-Chief at the Albany Medical Center Hospital in Albany, New York. The Pathology and Laboratory Medicine Department at Albany Medical Center is a large academic pathology and clinical laboratory practice and provides services to a network of community hospitals, multi-specialty physician groups, governmental agencies, extended care facilities and for-profit regional and national laboratory companies throughout upstate New York and western New England. This program was privatized in 2002 as Affiliated Pathology Services, Inc. with Dr. Ross serving as owner, President and Chief Executive Officer. In addition to the Albany medical Center, APS provides pathology services at the Health Alliance Hospitals of Kingston, NY and the Health Quest Hospitals of Rhinebeck and Poughkeepsie, NY. Dr. Ross has received numerous academic awards, four patents in molecular diagnostics (including HER2 gene amplification detected by fluorescence in situ hybridization) and is the author of more than 630 peer-reviewed scientific articles and abstracts, 4 textbooks and numerous book chapters in the fields of pathology, molecular diagnostics, oncology and translational cancer research. At Albany Medical College, Dr. Ross directs an extramurally funded research laboratory in molecular pathology. Dr. Ross has been a member of the NIH Clinical Oncology Study Section. He serves on the editorial boards and reviewer lists of numerous scientific journals and is Associate Editor for Basic Science of the American Journal of Clinical Pathology. He has served in multiple leadership positions for the American Society of Clinical Pathologists, the College of American Pathologists, the International Academy of Pathology, the Association of Pathology Chairs and the American Society of Clinical Oncology. From 1999 to 2004, Dr. Ross served as Scientific Fellow and Head of Molecular Pathology at Millennium Pharmaceuticals, Inc. of Cambridge, MA. In 2004, Dr. Ross co-founded SYFR, Inc. an RFID Specimen Management and IHC/ISH/FISH autostainer company. Dr. Ross is a Founding Strategic Advisor and the Medical Director for Foundation Medicine, Inc. in Cambridge, MA. Dr. Ross also currently serves as consultant and/or scientific advisory board member for Roche-Genentech, Dako, Daiichi-Sankyo, Welch-Allyn, Novartis, Veridex, EMD Merck Serono, Bristol Myers Squibb, Inc., Abbott Molecular, Inc., Boehringer-Ingelheim, President of Affiliated Pathology Services, PC and Chairman of the Department of Pathology and Laboratory Medicine at the Albany Medical College and Pathologist in Chief at the Albany Medical Center Hospital.
Leadership position/advisory role for: Foundation Medicine, Inc.
Stockholder in: Foundation Medicine, Inc.; Syfr, Inc.
Patents and royalties from: Various Oncology and Pathology textbooks
Honoraria (lecture fee) from: Genentech/Roche, Inc.; Bristol Myers Squibb, Inc.; Boehringer-Ingelheim, Inc.; Pfizer, Inc.; Daiichi-Sankyo, Inc.
Honoraria (manuscript fee) from: None
Grant/Research funding from: Foundation Medicine, Inc.; BluePrint Medicines, Inc.; Daiichi-Sankyo, Inc.
Other remuneration from: None
Employee of: Foundation Medicine, Inc.